Bellator MMA moves forward this Saturday in London for Bellator 158, and they're getting some help frm the Mohegan Department of Athletic Regulation for the the event.
Mohegan will conduct pre-and-post fight drug testing for the event in an effort to prevent any competitive advantages. While out-of-competition testing isn't something Bellator has done for this card, it has been met with mixed results for the UFC and their relationship with the United States Anti-Doping Agency.
You can see Bellator's press release on the decision below. Fightful.com will have exclusives on the event with Michael "Venom" Page and Paul Daley this week.
Bellator is pleased to announce that the promotion will be receiving regulatory support from the Mohegan Department of Athletic Regulation for the “Bellator 158: London” event this Saturday at The O2 in London, England.
The athletic commission will be conducting regulatory drug testing on the “Bellator 158: London” combatants both pre and post-fight.
Bellator Director of Regulatory Affairs and ISKA President, Cory Schafer commented, “I couldn’t be more pleased to have the Mohegan commission’s involvement in Bellator’s upcoming international event. It will help establish a level of regulatory consistency that clearly serves the best interest of the promotion and the athletes. We look forward to very successful and well-regulated event.”
The “Bellator 158: London” event is going to be a can’t-miss blockbuster featuring the always-entertaining British sensation Paul Daley (38-13-2) against Brazilian knockout specialist Douglas Lima (26-6) in the main event. Former NFL player Matt Mitrione (10-5) will face former “Britain’s Strongest Man” winner, Oli Thompson (17-8) in the co-main event. Michael “Venom” Page (10-0) aims to continue his raging pace and remain unbeaten when he challenges MMA veteran “Cyborg” Santos (21-17), and Lukasz Klinger (7-2) makes his promotional debut against Francis Carmont (24-11).
By Fightful Staff -
